Blood pressure lowering in the prevention of type 2 diabetes

Affiliations

¹ Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: matt.cavender@unc.edu.
² Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Comment

Matthew A Cavender et al. Lancet. 2021.

. 2021 Nov 13;398(10313):1778-1779.

doi: 10.1016/S0140-6736(21)02340-0.

¹ Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: matt.cavender@unc.edu.
² Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

No abstract available

Comment on

Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis.
Nazarzadeh M, Bidel Z, Canoy D, Copland E, Wamil M, Majert J, Smith Byrne K, Sundström J, Teo K, Davis BR, Chalmers J, Pepine CJ, Dehghan A, Bennett DA, Smith GD, Rahimi K; Blood Pressure Lowering Treatment Trialists’ Collaboration. Nazarzadeh M, et al. Lancet. 2021 Nov 13;398(10313):1803-1810. doi: 10.1016/S0140-6736(21)01920-6. Lancet. 2021. PMID: 34774144 Free PMC article.